Recent advances in the systemic treatment of gastrointestinal stromal tumors

GISTs represent a relatively rare entity; however, GISTs are still the most common mesenchymal neoplasm in the gastrointestinal tract. The majority of GISTs express the transmembrane receptor, KIT, a product of the KIT proto-oncogene that can lead to uncontrolled cell proliferation and resistance to